Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.49-1.76 (-13.28%)
At close: 4:00PM EDT
11.46 -0.03 (-0.26%)
After hours: 07:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.25
Open12.94
Bid11.60 x 1200
Ask11.95 x 1800
Day's Range11.31 - 12.94
52 Week Range7.11 - 18.88
Volume766,583
Avg. Volume2,574,420
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • TipRanks

    Jasper Therapeutics Stock Is up 127% in Three Days. How Much Higher Can It Go?

    There’s a new biotech in town flying under the Street’s radar. Jasper Therapeutics (JSPR) only went public in September via the SPAC route, and the stock still has a low profile on Wall Street. One analyst, however, has been taking notes, and he is decidedly positive. “We view JSPR as an emerging leader in the development of novel targeted conditioning agents for hematopoietic stem cell transplantation (HSCT) with lead candidate JSP191 and proprietary engineered hematopoietic stem cell (eHSC) pl

Advertisement
Advertisement